Our results demonstrated that treatment of EVI1high AML cells with PIP/56-1 or PIP/56-2 efficiently inhibits GPR56 expression and suppresses cell growth with concomitant induction of p53-dependent apoptosis. This evidence concerns the gene TP53 and acute myeloid leukemia.